2022-04-012023-03-312023-03-31false07952383REXYN LTD2023-11-02iso4217:GBPxbrli:pure079523832022-04-01079523832023-03-31079523832022-04-012023-03-31079523832021-04-01079523832022-03-31079523832021-04-012022-03-3107952383bus:SmallEntities2022-04-012023-03-3107952383bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3107952383bus:AbridgedAccounts2022-04-012023-03-3107952383bus:PrivateLimitedCompanyLtd2022-04-012023-03-3107952383core:WithinOneYear2023-03-3107952383core:AfterOneYear2023-03-3107952383core:WithinOneYear2022-03-3107952383core:AfterOneYear2022-03-3107952383core:ShareCapital2023-03-3107952383core:SharePremium2023-03-3107952383core:RevaluationReserve2023-03-3107952383core:OtherReservesSubtotal2023-03-3107952383core:RetainedEarningsAccumulatedLosses2023-03-3107952383core:ShareCapital2022-03-3107952383core:SharePremium2022-03-3107952383core:RevaluationReserve2022-03-3107952383core:OtherReservesSubtotal2022-03-3107952383core:RetainedEarningsAccumulatedLosses2022-03-3107952383core:LandBuildings2023-03-3107952383core:PlantMachinery2023-03-3107952383core:Vehicles2023-03-3107952383core:FurnitureFittings2023-03-3107952383core:OfficeEquipment2023-03-3107952383core:NetGoodwill2023-03-3107952383core:IntangibleAssetsOtherThanGoodwill2023-03-3107952383core:ListedExchangeTraded2023-03-3107952383core:UnlistedNon-exchangeTraded2023-03-3107952383core:LandBuildings2022-03-3107952383core:PlantMachinery2022-03-3107952383core:Vehicles2022-03-3107952383core:FurnitureFittings2022-03-3107952383core:OfficeEquipment2022-03-3107952383core:NetGoodwill2022-03-3107952383core:IntangibleAssetsOtherThanGoodwill2022-03-3107952383core:ListedExchangeTraded2022-03-3107952383core:UnlistedNon-exchangeTraded2022-03-3107952383core:LandBuildings2022-04-012023-03-3107952383core:PlantMachinery2022-04-012023-03-3107952383core:Vehicles2022-04-012023-03-3107952383core:FurnitureFittings2022-04-012023-03-3107952383core:OfficeEquipment2022-04-012023-03-3107952383core:NetGoodwill2022-04-012023-03-3107952383core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107952383core:ListedExchangeTraded2022-04-012023-03-3107952383core:UnlistedNon-exchangeTraded2022-04-012023-03-3107952383core:MoreThanFiveYears2022-04-012023-03-3107952383core:Non-currentFinancialInstruments2023-03-3107952383core:Non-currentFinancialInstruments2022-03-3107952383dpl:CostSales2022-04-012023-03-3107952383dpl:DistributionCosts2022-04-012023-03-3107952383core:LandBuildings2022-04-012023-03-3107952383core:PlantMachinery2022-04-012023-03-3107952383core:Vehicles2022-04-012023-03-3107952383core:FurnitureFittings2022-04-012023-03-3107952383core:OfficeEquipment2022-04-012023-03-3107952383dpl:AdministrativeExpenses2022-04-012023-03-3107952383core:NetGoodwill2022-04-012023-03-3107952383core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3107952383dpl:GroupUndertakings2022-04-012023-03-3107952383dpl:ParticipatingInterests2022-04-012023-03-3107952383dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3107952383core:ListedExchangeTraded2022-04-012023-03-3107952383dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3107952383core:UnlistedNon-exchangeTraded2022-04-012023-03-3107952383dpl:CostSales2021-04-012022-03-3107952383dpl:DistributionCosts2021-04-012022-03-3107952383core:LandBuildings2021-04-012022-03-3107952383core:PlantMachinery2021-04-012022-03-3107952383core:Vehicles2021-04-012022-03-3107952383core:FurnitureFittings2021-04-012022-03-3107952383core:OfficeEquipment2021-04-012022-03-3107952383dpl:AdministrativeExpenses2021-04-012022-03-3107952383core:NetGoodwill2021-04-012022-03-3107952383core:IntangibleAssetsOtherThanGoodwill2021-04-012022-03-3107952383dpl:GroupUndertakings2021-04-012022-03-3107952383dpl:ParticipatingInterests2021-04-012022-03-3107952383dpl:GroupUndertakingscore:ListedExchangeTraded2021-04-012022-03-3107952383core:ListedExchangeTraded2021-04-012022-03-3107952383dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-04-012022-03-3107952383core:UnlistedNon-exchangeTraded2021-04-012022-03-3107952383core:NetGoodwill2023-03-3107952383core:IntangibleAssetsOtherThanGoodwill2023-03-3107952383core:LandBuildings2023-03-3107952383core:PlantMachinery2023-03-3107952383core:Vehicles2023-03-3107952383core:FurnitureFittings2023-03-3107952383core:OfficeEquipment2023-03-3107952383core:AfterOneYear2023-03-3107952383core:WithinOneYear2023-03-3107952383core:ListedExchangeTraded2023-03-3107952383core:UnlistedNon-exchangeTraded2023-03-3107952383core:ShareCapital2023-03-3107952383core:SharePremium2023-03-3107952383core:RevaluationReserve2023-03-3107952383core:OtherReservesSubtotal2023-03-3107952383core:RetainedEarningsAccumulatedLosses2023-03-3107952383core:NetGoodwill2022-03-3107952383core:IntangibleAssetsOtherThanGoodwill2022-03-3107952383core:LandBuildings2022-03-3107952383core:PlantMachinery2022-03-3107952383core:Vehicles2022-03-3107952383core:FurnitureFittings2022-03-3107952383core:OfficeEquipment2022-03-3107952383core:AfterOneYear2022-03-3107952383core:WithinOneYear2022-03-3107952383core:ListedExchangeTraded2022-03-3107952383core:UnlistedNon-exchangeTraded2022-03-3107952383core:ShareCapital2022-03-3107952383core:SharePremium2022-03-3107952383core:RevaluationReserve2022-03-3107952383core:OtherReservesSubtotal2022-03-3107952383core:RetainedEarningsAccumulatedLosses2022-03-3107952383core:NetGoodwill2021-04-0107952383core:IntangibleAssetsOtherThanGoodwill2021-04-0107952383core:LandBuildings2021-04-0107952383core:PlantMachinery2021-04-0107952383core:Vehicles2021-04-0107952383core:FurnitureFittings2021-04-0107952383core:OfficeEquipment2021-04-0107952383core:AfterOneYear2021-04-0107952383core:WithinOneYear2021-04-0107952383core:ListedExchangeTraded2021-04-0107952383core:UnlistedNon-exchangeTraded2021-04-0107952383core:ShareCapital2021-04-0107952383core:SharePremium2021-04-0107952383core:RevaluationReserve2021-04-0107952383core:OtherReservesSubtotal2021-04-0107952383core:RetainedEarningsAccumulatedLosses2021-04-0107952383core:AfterOneYear2022-04-012023-03-3107952383core:WithinOneYear2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3107952383core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3107952383core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3107952383core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3107952383core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3107952383core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3107952383core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3107952383core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3107952383core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3107952383core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3107952383core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3107952383core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3107952383core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3107952383core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3107952383core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3107952383core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3107952383core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3107952383core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3107952383core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3107952383bus:Director12022-04-012023-03-31

REXYN LTD

Registered Number
07952383
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

REXYN LTD
Company Information
for the year from 1 April 2022 to 31 March 2023

Director

JASANI, Yogen

Registered Address

Suite 312 Atlas House Caxton Close
Wigan
WN3 6XU

Registered Number

07952383 (England and Wales)
REXYN LTD
Balance Sheet as at
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets713,71817,694
Tangible assets8103162
13,82117,856
Current assets
Stocks115,58194,150
Debtors928,4061,352
Cash at bank and on hand38,13533,312
182,122128,814
Creditors amounts falling due within one year10(248,548)(250,578)
Net current assets (liabilities)(66,426)(121,764)
Total assets less current liabilities(52,605)(103,908)
Creditors amounts falling due after one year(14,983)(19,600)
Net assets(67,588)(123,508)
Capital and reserves
Called up share capital11
Profit and loss account(67,589)(123,509)
Shareholders' funds(67,588)(123,508)
The financial statements were approved and authorised for issue by the Director on 2 November 2023, and are signed on its behalf by:
JASANI, Yogen
Director
Registered Company No. 07952383
REXYN LTD
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Principal activities
The principal activity of the company in the period under review was that of the sale of healthcare products and online retail.
4.Basis of measurement used in financial statements
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
5.Accounting policies
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Plant and machinery-5
Office Equipment25-
Intangible assets policy
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. Patents and licences are being amortised evenly over their estimated useful life of 15 years.
Stocks policy
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Going concern
The accounts have been prepared on the going concern basis of accounting, on the assumption that the director and the company's bankers will continue to provide financial support to enable the company to meet its current liabilities, which exceeded its current assets at 31st March 2021.
6.Employee information

20232022
Average number of employees during the year00
7.Intangible assets

Total

£
Cost or valuation
At 01 April 22138,436
At 31 March 23138,436
Amortisation and impairment
At 01 April 22120,742
Charge for year3,976
At 31 March 23124,718
Net book value
At 31 March 2313,718
At 31 March 2217,694
8.Property, plant and equipment

Total

£
Cost or valuation
At 01 April 2225,727
At 31 March 2325,727
Depreciation and impairment
At 01 April 2225,566
Charge for year58
At 31 March 2325,624
Net book value
At 31 March 23103
At 31 March 22162
9.Debtors

2023

2022

££
Trade debtors / trade receivables28,4061,352
Total28,4061,352
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
10.Creditors within one year

2023

2022

££
Trade creditors / trade payables14,17410,281
Bank borrowings and overdrafts4,6174,132
Taxation and social security7,2003,138
Other creditors222,557233,027
Total248,548250,578
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.